Australia markets open in 1 hour 9 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
77.13+0.43 (+0.56%)
At close: 04:00PM EDT
77.25 +0.12 (+0.16%)
After hours: 06:36PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close76.70
Open76.70
Bid76.77 x 1200
Ask77.43 x 900
Day's range76.41 - 77.72
52-week range53.22 - 78.47
Volume13,238,177
Avg. volume15,450,429
Market cap164.214B
Beta (5Y monthly)0.48
PE ratio (TTM)27.32
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.16 (2.82%)
Ex-dividend date31 Mar 2022
1y target estN/A
  • Motley Fool

    Why Roche Needs to Invest in At-Home Diagnostics

    As the leader in medical diagnostics, Roche (OTC: RHHB.F) acted quickly to deliver valuable COVID-19 screening tests to the marketplace. Assisted by COVID-related sales, its diagnostics divisionΒ is now delivering stronger growth than its larger pharmaceuticals division. Roche's medical diagnostics division saw strong growth throughout 2021 and into the begining of 2022.

  • Zacks

    Merck's (MRK) Keytruda Gets CHMP Nod for Expanded Melanoma Use

    Merck's (MRK) anti-PD-1 therapy Keytruda nears potential approval as an adjuvant treatment for adolescent pediatric patients with stage IIB, IIC or III melanoma following complete resection.

  • Zacks

    Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer

    Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.